-
COMPANY REVIEW
Tanvex BioPharma, Inc. is a modern pharmaceutical company in the clinical stage of commercial development. Planned by Dr. Allen Chao, formerly founder and CEO of Watson Pharmaceuticals, Tanvex BioPharma is making new biopharmaceutical products more accessible.
-
NEWS
Check out the latest news about Tanvex BioPharma and developments in the biopharmaceutical industry.
- Sep 4th, 2024 Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
- Aug 27st, 2024 Tanvex Forging Strategic Alliance with Bora Pharmaceuticals
- Aug 1st, 2024 FDA accepts TX05 BLA resubmission
- Jul 8th, 2024 TX05 BLA resubmisson
- Jul 1st, 2024 Tanvex received BLA approval from FDA
-
INTRODUCTION